Why Is Dermata Therapeutics Stock Surging Wednesday?

Benzinga_recent_news2025-12-25

Dermata Therapeutics, Inc. (NASDAQ:DRMA) stock rose Wednesday after the company disclosed that it has entered into definitive agreements for a private placement offering of around $12.4 million. The ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2594405411?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/24/Ipo-Initial-Public-Offering--Business-Ma.jpeg?optimize=medium&dpr=2&auto=webp&width=240","is_english":true,"pubTime":"2025-12-25 00:32","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2594405411","market":"hk","top_or_hot":-1,"title":"Why Is Dermata Therapeutics Stock Surging Wednesday?","media":"Benzinga_recent_news","content":"<div>\n<p>Dermata Therapeutics, Inc. (NASDAQ:DRMA) stock rose Wednesday after the company disclosed that it has entered into definitive agreements for a private placement offering of around $12.4 million.\nThe ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/25/12/49585324/why-is-dermata-therapeutics-stock-surging-wednesday\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Is Dermata Therapeutics Stock Surging Wednesday?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Is Dermata Therapeutics Stock Surging Wednesday?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-25 00:32 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/trading-ideas/movers/25/12/49585324/why-is-dermata-therapeutics-stock-surging-wednesday><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dermata Therapeutics, Inc. (NASDAQ:DRMA) stock rose Wednesday after the company disclosed that it has entered into definitive agreements for a private placement offering of around $12.4 million.\nThe ...</p>\n\n<a href=\"https://www.benzinga.com/trading-ideas/movers/25/12/49585324/why-is-dermata-therapeutics-stock-surging-wednesday\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/12/49585324/why-is-dermata-therapeutics-stock-surging-wednesday","article_id":"2594405411","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/24/Ipo-Initial-Public-Offering--Business-Ma.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/12/49585324/why-is-dermata-therapeutics-stock-surging-wednesday","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2594405411","pubTimestamp":1766593920,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Dermata Therapeutics rose after announcing a private placement offering of common shares, Series C warrants, and Series D warrants.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4539":"次新股","DRMA":"Dermata Therapeutics Inc","BK4139":"生物科技","BK4007":"制药"},"translate_title":"为什么Dermata Therapeutics股价周三飙升？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DRMA":1.5},"content_text":"Dermata Therapeutics, Inc. (NASDAQ:DRMA) stock rose Wednesday after the company disclosed that it has entered into definitive agreements for a private placement offering of around $12.4 million.\nThe offering included private placement of 2,022,062 common shares (or pre-funded warrants), Series C warrants, and short-term Series D warrants, all priced at $2.04 per share under Nasdaq's at-the-market rules.\nThe warrants, exercisable upon stockholder approval, expire in five years (Series C) and 24 months (Series D).\nThe offering is expected to close around December 29, 2025, with company insiders participating at the same terms as other investors.\nDermata Therapeutics expects to raise around $4.1 million in gross proceeds from the offering, before fees and expenses.\nIf fully exercised, the Series C and short-term Series D warrants could provide an additional $8.3 million, though there is no guarantee the warrants will be exercised.\nThe company plans to use the net proceeds for general corporate purposes, including consumer research, pre-launch and launch activities for its OTC acne kit, investments or acquisitions of complementary or emerging technology companies, licensing activities, and working capital.\nThe company has also agreed to amend certain outstanding warrants for 120,734 shares of common stock, originally issued on January 23, 2025, with an exercise price of $12.70 per share (adjusted for a one-for-10 reverse stock split on July 30, 2025).\nPost closure, the amended warrants will have a reduced exercise price of $2.04 per share, become exercisable upon stockholder approval, and expire five years from that date.\nCurrently, the company has 1,175,798 shares of common stock issued and outstanding.\nDRMA Price Action: Dermata Therapeutics shares were up 20.10% at $2.45 at the time of publication on Wednesday. The stock is trading near its 52-week low of $1.96, according to Benzinga Pro data.\nRead Next:\nImage via Shutterstock","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2594405411","isCrawlerRequest":true}